Startup profile · funding coverage
General Medicine funding, valuation and investors
Consumer healthcare marketplace for comparing and buying medications, labs, telehealth and care services.
Verified company research · funding, investors and latest developments
Keep track of General Medicine
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series B
$120M · October 6, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$120M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series b · San Francisco, California, United States
Investors in latest funding
Lead: Andreessen Horowitz
Other: Matrix , VXI Capital , Eli Lilly and Company , Granger Management , BoxGroup
Overview
General Medicine operates a nationwide healthcare store in the United States with a catalog spanning medications, labs, telehealth, specialist e-consults and selected in-person services.
Why General Medicine is interesting
General Medicine is trying to package fragmented healthcare purchasing into a consumer-style catalog with upfront pricing both with and without insurance.
Funding history (newest first)
Series B
2026-10-06 $120M- Andreessen Horowitz (lead)
- Matrix (participant)
- VXI Capital (participant)
- Eli Lilly and Company (participant)
- Granger Management (participant)
- BoxGroup (participant)
Source: Read source · prnewswire.com
Market / IPO context
Editorial / static context — not a live quote.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.